Skip to main content
Glama

Clinical Trials Search - ClinicalTrials.gov studies

clinical_trials
Read-onlyIdempotent

Search ClinicalTrials.gov (official v2 API) by keyword, condition, intervention, sponsor or location. Returns NCT id, title, status, phases, enrollment, conditions, interventions, sponsor, dates and countries. Free: 25 calls/day per IP. Paid: $0.005 per call via x402 at https://localhost/x402/clinical-trials.

Input Schema

NameRequiredDescriptionDefault
queryNoFree-text search
statusNoOverall status
sponsorNoSponsor, e.g. Pfizer
locationNoLocation, e.g. Germany
maxItemsNoMax results (1-50)
conditionNoCondition, e.g. diabetes
interventionNoDrug or intervention, e.g. semaglutide

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observed

TDQS

A3.8/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, and idempotentHint, so the safety profile is covered. The description adds useful behavioral context beyond annotations: the official v2 API, returned fields, a 25 calls/day free limit, and paid x402 access. It does not describe pagination or error behavior, but the added rate-limit and cost details are meaningful.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is three tight sentences with no wasted wording. It front-loads the core search capability, then return fields, then access limits and pricing.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a read-only search tool with full schema coverage and annotations, the description is nearly complete: it covers purpose, return fields, rate limits, and cost. It could mention pagination or result ordering, but no critical calling information is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so all seven parameters are already documented in the input schema. The description lists the same search dimensions but adds no syntax, format, or interaction details beyond what the schema provides, making the baseline 3 appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: search ClinicalTrials.gov, and it names the supported search dimensions (keyword, condition, intervention, sponsor, location). It does not explicitly differentiate this tool from siblings such as web_read or domain_intel, so it falls short of a 5.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description implies when to use the tool by describing it as a ClinicalTrials.gov search, but it gives no explicit when-not guidance or alternatives. An agent can infer the use case, but routing versus sibling tools is left to inference.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources